Medical Dosimetry
Volume 35, Issue 3 , Pages 163-168, Autumn 2010

Internal Mammary Lymph Node Irradiation Contributes to Heart Dose in Breast Cancer

Presented in part at the annual meeting of the European Society for Therapeutic Radiology and Oncology, Götenborg, Sweden, September 14–17th, 2008.

  • Cyrus Chargari, M.D.

      Affiliations

    • Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
    • Department of Radiotherapy and Medical Oncology, Hôpital d'Instruction des Armées du Val-de-Grâce, Paris, France
  • ,
  • Pierre Castadot, M.D., Ph.D.

      Affiliations

    • Department of Radio-Oncology, Institut Jules Bordet, Brussels, Belgium
  • ,
  • Dhara MacDermed, M.D.

      Affiliations

    • Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL
  • ,
  • Christophe Vandekerkhove, Ph.D.

      Affiliations

    • Department of Medical Physics, Institut Jules Bordet, Brussels, Belgium
  • ,
  • Nicolas Bourgois, M.D.

      Affiliations

    • Department of Radio-Oncology, Institut Jules Bordet, Brussels, Belgium
  • ,
  • Paul Van Houtte, M.D.

      Affiliations

    • Department of Radio-Oncology, Institut Jules Bordet, Brussels, Belgium
  • ,
  • Nicolas Magné, M.D., Ph.D.

      Affiliations

    • Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
    • Department of Radio-Oncology, Institut Jules Bordet, Brussels, Belgium
    • Corresponding Author InformationReprint requests to: Nicolas Magné, M.D., Ph.D., Institut Gustave-Roussy, Department of Radiotherapy, 39, rue Camille Desmoulins, 94805 Villejuif cedex, France

Received 31 December 2008; accepted 5 May 2009. published online 26 June 2009.

Abstract 

We assessed the impact of internal mammary chain radiotherapy (IMC RT) to the radiation dose received by the heart in terms of heart dose-volume histogram (DVH). Thirty-six consecutive breast cancer patients presenting with indications for IMC RT were enrolled in a prospective study. The IMC was treated by a standard conformal RT technique (50 Gy). For each patient, a cardiac DVH was generated by taking into account the sole contribution of IMC RT. Cardiac HDV were compared according to breast cancer laterality and the type of previous surgical procedure, simple mastectomy or breast conservative therapy (BCT). The contribution of IMC RT to the heart dose was significantly greater for patients with left-sided versus right-sided tumors (13.8% and 12.8% for left-sided tumors versus 3.9% and 4.2% for right-sided tumors in the BCT group and the mastectomy group, respectively; p < 0.0001). There was no statistically significant difference in IMC contribution depending on the initial surgical procedure. IMC RT contributes to cardiac dose for both left-sided and right-sided breast cancers, although the relative contribution is greater in patients with left-sided tumors.

Key Words: Breast cancer, Internal mammary chain, Radiotherapy, Dosimetry

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0958-3947(09)00049-1

doi:10.1016/j.meddos.2009.05.002

Medical Dosimetry
Volume 35, Issue 3 , Pages 163-168, Autumn 2010